Table 3.
Recurrence rates in patients with negative nodes, micrometastases, and isolated tumor cells.
| First Author | Number of Patients |
Recurrences in Patients with Negative Nodes (%) | Recurrences in Patients with MM (%) | Recurrences in Patients with ITCs (%) | Non-Vaginal Recurrences in Patients with ITCs (%) | Recurrences in Patients with ITCs and Otherwise Low-Risk EC |
Follow-Up (Months) |
|---|---|---|---|---|---|---|---|
| Kim [49] | 508 | NR | NR | 2 (10.5) | 2 (10.5) | 0 | NR |
| Raimond [73] | 136 | 11 (9.7) | 1 (6.7) | NR | NR | NR | NR |
| Todo [74] | 61 | 8 (15) | 1 (33.3) | 3 (50) | 3 (50) | 0 | 107 |
| St Clair [82] | 844 | 47 (6) | 2 (9.5) | 2 (8.7) | 1 (4.3) | NR | 26 |
| Plante [63] | 519 | NR | NR | 1 (3.2) | 1 (3.2) | 0 | 29 |
| Backes [64] | 184 | NR | 1 (50) | 0 | 0 | 0 | 31 |
| Garcia Pineda [67] | 230 | NR | 2 (25) | 3 (33.3) | 0 | 1 | 60 |
| Lavecchia [59] | 1012 | 44 (4.6) | 1 (14.3) | 0 | 0 | 0 | 27 |
| Buda [68] | 1428 | 75 (5.9) | 6 (12) | 5 (19.2) | NR | NR | 33.3 |
| Backes [85] | 175 | 16 (3.5) | NR | 9 (5.1) | 8 (4.6) | 1 | 31 |
| Ghoniem [86] | 247 | NR | 21 (18.3) | 17 (12.9) | NR | 1 (of 18 with low-risk EC) | 29.6 |
| Cucinella [87] | 494 | 16 (3.5) | NR | 5 (11.9) | 4 (9.5) | Only low-risk patients included | 28 in ITCs and 31 in node-negative |
Abbreviations: EC: endometrial carcinoma; MM: micrometastases; ITCs: isolated tumor cells; NR: not reported.